Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
UBS
Boehringer Ingelheim
Healthtrust
McKinsey
Accenture
Daiichi Sankyo
Julphar
Cipla

Generated: October 18, 2017

DrugPatentWatch Database Preview

Patents Expiring in August 2023

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Allergan
LATISSE
bimatoprost
SOLUTION/DROPS;TOPICAL022369-001Dec 24, 2008ATRXYesYes► Subscribe► SubscribeYY TREATMENT OF HYPOTRICHOSIS OF THE EYELASHES BY INCREASING THEIR GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS
Merz Pharms
CUVPOSA
glycopyrrolate
SOLUTION;ORAL022571-001Jul 28, 2010RXYesYes► Subscribe► Subscribe REDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA)IN PATIENTS WITH NEUROLOGIC CONDITIONS ASSOCIATED WITH PROBLEM DROOLING
Merz Pharms
CUVPOSA
glycopyrrolate
SOLUTION;ORAL022571-001Jul 28, 2010RXYesYes► Subscribe► Subscribe REDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA)IN PATIENTS WITH NEUROLOGIC CONDITIONS ASSOCIATED WITH PROBLEM DROOLING
Bristol Myers Squibb
ZERIT XR
stavudine
CAPSULE, EXTENDED RELEASE;ORAL021453-004Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY
Bristol Myers Squibb
ZERIT XR
stavudine
CAPSULE, EXTENDED RELEASE;ORAL021453-003Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY
Bristol Myers Squibb
ZERIT XR
stavudine
CAPSULE, EXTENDED RELEASE;ORAL021453-002Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY
Bristol Myers Squibb
ZERIT XR
stavudine
CAPSULE, EXTENDED RELEASE;ORAL021453-001Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY
Theratechnologies
EGRIFTA
tesamorelin acetate
POWDER;SUBCUTANEOUS022505-001Nov 10, 2010RXYesYes► Subscribe► Subscribe REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY
Theratechnologies
EGRIFTA
tesamorelin acetate
POWDER;SUBCUTANEOUS022505-002Nov 29, 2011DISCNNoNo► Subscribe► Subscribe REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY
Boehringer Ingelheim
JENTADUETO
linagliptin; metformin hydrochloride
TABLET;ORAL201281-001Jan 30, 2012RXYesNo► Subscribe► Subscribe METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Covington
Cantor Fitzgerald
Cipla
Novartis
Merck
Dow
Moodys
Queensland Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot